Paper-based diagnostic test kits

Thermo Fisher Scientific and Dickinson appear among the corporate organizations associated with this topic, while Ahlstrom and Jabil Inc. are listed as patent holders with two patents each. SENSE4MED srl is a named startup developing paper-based electrochemical sensing. The available company profiles provide less detail on commercial kit portfolios than on research activity, so specific products and supplier roles should be verified.

SENSE4MED srl is the clearest named startup in the available data, with work on a paper-based electrochemical biosensor for phytic acid and a molecularly imprinted paper sensor for breath analysis. The dataset identifies 4 startups overall, but does not provide detailed product validation or commercialization data for all of them. Treat this as a starting point for diligence, not a ranking of prospects.

Chulalongkorn University leads the named organizations with 25 documents in the 24-month window, followed by the Chinese Academy of Sciences with 21 and Ohio State University with 14. Their work spans immunosensors, paper-microfluidic molecular assays and malaria surveillance. Other active groups include Zhejiang University, Keio University and Cranfield University, with research covering CRISPR, food and water testing, and image interpretation.

The reported totals are $14,395,135 across 24 grants since 2020 and $1,260,896,002 across 9 funding rounds. The round total includes broad financing records that may not be dedicated to paper diagnostics, so it should not be interpreted as sector-specific investment without checking each item. The grant figure is a separate funding signal and is also linked to the topic dataset.

Ahlstrom and Jabil Inc. are the leading named patent holders, with two patents each in the available records. University of Technology, Sydney, University of Southern California, Seoul National University of Science and Technology, and other listed organizations each have one. These figures describe patent records in the dataset and do not establish the scope, status or commercial relevance of each patent.

No: patent activity declined 69.2% in the latest 12-month comparison with the preceding 12 months, while publications rose 8.1%. The figures indicate that research output is not moving in step with patenting. They do not by themselves show whether the shift reflects fewer inventions, filing delays or changes in how relevant patents are classified.

Recent work combines paper microfluidics with digital or molecular functions. In October 2026, the University of Granada and University of Glasgow reported a smartphone-based, flow-controlled μPAD for colorimetric nitrite measurement. In August 2026, Cranfield University and Zhejiang University described a paper platform combining isothermal amplification and CRISPR/Cas12a for aquatic pathogens. A September 2026 study used laser-induced graphene for paper-based electrochemical immunoassays.

The main approaches are lateral-flow immunoassays, paper microfluidic colorimetry, electrochemical paper sensors, paper-based molecular assays, and chemical or enzymatic test strips. They differ in how they recognize a target and produce a readout: antibodies or enzymes can create visible signals, molecular assays amplify genetic targets, and electrochemical sensors measure electrical changes. Greater quantification or specificity can require more complex fabrication, reagents or equipment.

Recorded applications include food and water safety, infectious disease testing, metabolic and chronic disease testing, pregnancy and reproductive health, and veterinary and agricultural testing. Food and water safety has 164 documents, while infectious disease testing has 112. Recent examples include paper assays for aquatic pathogens, foodborne bacteria and biomarkers. These categories reflect documented research and do not indicate that each application has a validated commercial kit.